New Combination Therapy Shows Promise in Reducing Lifelong Ibrutinib Use for Chronic Lymphocytic Leukemia
In a groundbreaking advancement for the treatment of chronic lymphocytic leukemia (CLL), researchers have unveiled promising results from a phase ...
